🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Strata Critical Medical, Inc. SRTA R2K

Healthcare · Medical Care Facilities · United States
https://www.stratacritical.com

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

READ MORE ›
$6.31
+80.80% 1Y

Market & Price

Market Cap
$545.98M
Current Price
$6.31
High / Low (52W)
$6.47 / $3.49
Beta
2.15

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
-
PEG Ratio
-
Book Value
$3.30
Price to Book
1.91
P/S
2.39
EV/EBITDA
-843.33
Dividend Yield
-

Profitability & Returns

ROCE
-7.31%
ROE
-6.35%
ROA
-1.91%
Profit Margin
20.56%
Op Margin
-2.83%
EPS (Latest Qtr)
$0.03
EPS (TTM)
$-0.19

Balance Sheet & Liquidity

Debt/Equity
1.56
Quick Ratio
4.70
Current Ratio
5.93
Debt
$4.47M
Total Assets
$325.47M
Current Assets
$126.19M
Working Capital
$106.40M

Ownership

Promoter Holding
13.88%
Chg in Prom Hold
-
FII / Inst Holding
78.96%
Chg in FII Hold
-0.47%

Financial Snapshot

Enterprise Value
$491.66M
Total Revenue (TTM)
$228.58M
EBITDA
$-583.00K
Free Cash Flow
$-24.45M
Operating Cash Flow
$-44.78M
Shares Outstanding
86.53M
Gross Margin
21.08%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
10.50%
Profit 5Y
83.89%
Revenue (YoY)
87.40%
Earnings (YoY)
-

PROS

  • Excellent profit margin of 20.6%.
  • Compounding revenue at 10.5% over 5 years.
  • Profit CAGR of 83.9% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SRTA Strata Critical Medical, Inc. R2K 6.31 - $545.98M - -7.31% -6.35% 10.50% 83.89%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --3.44M-9.27M12.95M20.32M24.62M26.63M35.63M45.72M-45.27M60.99M71.44M51.51M67.94M--35.95M70.80M49.30M66.79M67.38M
Cost of Revenue -------------------28.89M53.06M37.68M55.12M53.27M
Gross Profit --------2.92M5.11M9.27M-7.16M10.37M15.58M----7.05M17.74M11.61M11.67M14.12M
Operating Expenses -------------------12.74M22.69M17.24M18.07M17.09M
Operating Income -43.05K-145.13K-1.48M-160.69K-4.22M-7.77M-9.73M-10.54M-13.69M-9.73M-10.43M--12.83M-12.21M-7.45M-9.87M-12.15M---5.68M-4.95M-5.62M-6.41M-2.97M
EBITDA --------------------3.99M-3.18M-3.92M-3.40M86.00K
Interest Expense ------------------------
Pretax Income --------------------1.61M-3.72M-9.66M-5.39M2.40M
Tax Provision -------------------021.00K000
Net Income 99.14K5.70M-1.32M-100.16K-4.22M-24.29M-9.18M772.00K-11.01M8.41M-9.24M-27.26M-10.19M-12.23M289.00K-4.23M-11.33M---3.49M-3.74M57.42M-8.83M2.15M
Diluted EPS -----0.16-0.47-0.130.01-0.160.10-0.13--0.14-0.170.00-0.06-0.15---0.04-0.050.70-0.100.03

Profit & Loss (Annual)

Figures in USD.

Metric Sep 2019Sep 2020Dec 2020Sep 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 31.20M23.43M--146.12M225.18M146.82M197.14M
Cost of Revenue ----123.84M183.06M117.23M156.01M
Gross Profit ----22.27M42.12M29.59M41.13M
Operating Expenses ----75.80M110.24M52.11M63.48M
Operating Income -11.54M-10.36M-678.49K--53.53M-68.12M-22.52M-22.35M
EBITDA -----47.80M-61.01M-16.56M-14.17M
Interest Expense --------
Pretax Income -----28.03M-57.54M-16.16M-20.07M
Tax Provision -----772.00K-1.47M00
Net Income -10.84M-10.16M127.72K--27.26M-56.08M-27.31M41.35M
Diluted EPS -0.43-0.40---0.38-0.76-0.340.50

Compounded Sales Growth

5 Years:10.50%
1 Year:87.40%

Compounded Profit Growth

5 Years:83.89%
1 Year:-

Stock Price Performance

1 Year:+80.80%
6 Months:+49.17%
3 Months:+47.43%
1 Month:+28.78%

Balance Sheet (Annual)

Figures in USD.

Metric Sep 2018May 2019Sep 2019Dec 2019Sep 2020Dec 2020Sep 2021Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ---277.69M17.71M277.84M--325.02M294.94M256.68M325.47M
Current Assets --------218.13M206.26M160.74M126.19M
Cash & Equivalents --22.18M1.31M12.16M846.07K--41.34M27.87M16.07M30.97M
Inventory ------------
Receivables --------10.88M21.00M19.82M39.96M
Total Liabilities ---10.00M6.63M10.02M--50.54M60.64M34.74M46.40M
Current Liabilities ---371.31K6.34M390.79K--26.61M35.49M22.73M19.79M
Long Term Debt ------------
Total Debt --------18.33M24.52M3.02M3.31M
Total Equity 31.14M020.73M5.00M11.08M5.00M--274.49M234.30M221.94M279.07M
Shares Outstanding --------71.66M75.13M79.42M86.70M

Cash Flows (Annual)

Figures in USD.

Metric Sep 2019Sep 2020Dec 2020Sep 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -10.30M-10.82M-794.47K--37.13M-32.35M-2.52M-48.91M
Investing Cash Flow -1.05M-377.00K334.93K-79.34M17.09M-1.02M69.75M
Financing Cash Flow 116.00K1.18M---1.08M-76.00K-5.76M-8.91M
Capital Expenditure -604.00K-377.00K---730.00K-2.11M-32.98M-11.01M
Free Cash Flow -10.91M-11.20M---37.86M-34.46M-35.50M-59.92M
Net Change in Cash ----41.13M-15.34M-9.29M11.92M
Share Buybacks -----0244.00K0

Ratios (Annual)

Figures in %.

Metric Sep 2019Sep 2020Dec 2020Sep 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ----15.2%18.7%20.2%20.9%
Operating Margin % -37.0%-44.2%---36.6%-30.3%-15.3%-11.3%
Net Margin % -34.7%-43.4%---18.7%-24.9%-18.6%21.0%
ROE % -52.3%-91.7%2.6%--9.9%-23.9%-12.3%14.8%
ROCE % --91.1%-0.2%--17.9%-26.3%-9.6%-7.3%

Shareholding Pattern

Insiders
13.88%
Institutions
78.96%
Public Float
91.69%

Top Institutional Holders

#Holder% HeldSharesValue
1 ARK Investment Management, LLC 8.62% 7.46M $47.04M
2 Third Point, LLC 5.78% 5.00M $31.55M
3 Blackrock Inc. 5.28% 4.57M $28.83M
4 Northern Right Capital Management, L.P. 4.73% 4.09M $25.81M
5 Vanguard Capital Management LLC 3.32% 2.87M $18.13M
6 AWM Investment Company, Inc. 3.26% 2.82M $17.80M
7 Royce & Associates LP 3.25% 2.82M $17.77M
8 Pillsbury Lake Capital LLC 3.01% 2.60M $16.43M
9 First Eagle Investment Management, LLC 2.62% 2.27M $14.30M
10 Geode Capital Management, LLC 1.96% 1.70M $10.73M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SRTA

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space